An Integrated Oncology Platform for Biomarker - CDx Development
Thursday October 15th, 15-15:30pm PDT
Greater preclinical knowledge is needed on patient responder subgroups, and the genetic background behind their response, to improve patient clinical stratification and reduce attrition rates. This knowledge helps to design smarter oncology trials and to speed up the development of next-generation cancer therapies and companion diagnostics.
Visit the CrownBio Booth to Download Our Poster
An Automated Biomarker Discovery Platform based on In Vitro Pharmacology Raw Data
Learn more about the development of an automated biomarker discovery platform for in vitro preclinical pharmacology studies, combining an integrated suite of software facilities for data manipulation, calculation, and graphical display.